Business & Industry
Business & Industry
Global Lab Instrument Market Forecast to Grow by 6.3% CAGR
An analysis by BCC Research shows that the market for analytical laboratory instruments will grow at a compound annual growth rate (CAGR) of 6.3% from 2023 to 2028, rising from $60.9 billion in 2023 to $82.5 billion by 2028.
The...
Business & Industry
AI in Pharma Market Access and Commercialization: Transforming Pricing and Tender Strategies
The pharmaceutical industry is undergoing a profound transformation in how it approaches pricing decisions, market access negotiations, and tender participation through the strategic deployment of artificial intelligence technologies. AI in pharma market access represents a paradigm shift from traditional...
Business & Industry
FDA Looking to Lower Drugs Cost for All Americans
The Food and Drug Administration is looking to speed the development when it comes to biosimilars and has announced new guidelines, which would no longer want the makers of copycat biologics to indulge in human trials, therefore showing that...
Business & Industry
GSK Licences COPD Drug from Empirico for $85 Million Upfront
In just a space of 24 hours, GSK, in its second pipeline-expanding deal, has gone on to license the rights to a drug for chronic obstructive pulmonary disease – COPD from Empirico, the US biotech, for $85 million, and...
Business & Industry
KLN Named Exclusive Distributor for Siemens Healthineers Point-of-Care Testing Solutions in Hong Kong
KLN Logistics Group Limited announced a strategic partnership between its healthcare subsidiary, KLN Medical Limited (‘KLN Medical’), and global medical technology leader Siemens Healthineers AG (Stock Code SHL.DE). KLN Medical will serve as the exclusive distributor for Siemens Healthineers’...
BioPharma
CDMO Market for AAV Therapies to Hit $2.566 Billion By 2033
With a focus on Adeno-Associated Virus (AAV), the worldwide market for Contract Development and Manufacturing Organizations (CDMMOs) that biomanufacture cell and gene therapies has shown spectacular development, estimated to reach $0.2313 billion in 2022. Based on projections, this market...
BioPharma
Pharmaceutical CMO Market is Set for a 7.29% CAGR by 2028
It is projected that the market for pharmaceutical contract manufacturing organizations (CMOs) would expand at a compound annual growth rate (CAGR) of 7.29 percent until the year 2028. This rise may be ascribed to the expanded pharmaceutical industry, which...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read
















